Product NDC: | 0069-0126 |
Proprietary Name: | Famotidine |
Non Proprietary Name: | FAMOTIDINE |
Active Ingredient(s): | 10 mg/mL & nbsp; FAMOTIDINE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0069-0126 |
Labeler Name: | Pfizer Laboratories Div Pfizer Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078641 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110510 |
Package NDC: | 0069-0126-02 |
Package Description: | 10 VIAL, MULTI-DOSE in 1 CARTON (0069-0126-02) > 20 mL in 1 VIAL, MULTI-DOSE (0069-0126-01) |
NDC Code | 0069-0126-02 |
Proprietary Name | Famotidine |
Package Description | 10 VIAL, MULTI-DOSE in 1 CARTON (0069-0126-02) > 20 mL in 1 VIAL, MULTI-DOSE (0069-0126-01) |
Product NDC | 0069-0126 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | FAMOTIDINE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20110510 |
Marketing Category Name | ANDA |
Labeler Name | Pfizer Laboratories Div Pfizer Inc |
Substance Name | FAMOTIDINE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |